Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gyger

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
L'Union Medicale Du Canada|October 1, 1986
[Acute lymphoblastic and nonlymphoblastic leukemia in 1st complete remission: consolidation treatment by intensive radio-chemotherapy followed by transplantation of HLA-A, B and Dr compatible allogeneic bone marrow]M Gyger, C Perreault, Y Bonny, et al.
Bone Marrow Transplantation|September 14, 1999
Mycobacterium tuberculosis infection in allogeneic bone marrow transplantation patientsM Aljurf, M Gyger, A Alrajhi, et al.
Journal of Clinical Pathology|March 16, 2002
Extramedullary myeloid cell tumours localised to the mediastinum: a rare clinicopathological entity with unique karyotypic featuresR Nounou, H Al-Zahrani H, D S Ajarim, et al.
European Journal of Haematology|April 1, 1989
Chronic B-cell lymphocytosisC Perreault, J Boileau, M Gyger, et al.
British Journal of Haematology|December 1, 1993
Allogeneic bone marrow transplantation following busulfan-cyclophosphamide with or without etoposide conditioning regimen for patients with acute lymphoblastic leukaemiaA von Bueltzingsloewen, R Bélanger, C Perreault, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemiaG Pichert, D C Roy, R Gonin, et al.
British Journal of Haematology|April 12, 2000
The spectrum of Fusarium infection in immunocompromised patients with haematological malignancies and in non-immunocompromised patients: a single institution experience over 10 yearsM O Musa, A Al Eisa, M Halim, et al.
Leukemia & Lymphoma|August 3, 2002
Monitoring of donor/recipient T-cell engraftment kinetics in myeloablative allogeneic stem cell transplantation using short tandem repeat amplification from cell lysatesC E Boumah, B Meyer, M Aljurf, et al.
Experimental Hematology|May 20, 1998
Quantitative assessment of hematopoietic chimerism after allogeneic bone marrow transplantation has predictive value for the occurrence of irreversible graft failure and graft-vs.-host diseaseM Gyger, C Baron, L Forest, et al.
Cancer Chemotherapy and Pharmacology|May 13, 1999
Two different schedules for integrating filgrastim as adjuvant therapy in the treatment of patients with advanced stage Hodgkin's lymphoma receiving MOPP/ABV hybrid chemotherapyG Cantin, B L'Espérance, L Yelle, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
L'Union Medicale Du Canada|October 1, 1986
[Acute lymphoblastic and nonlymphoblastic leukemia in 1st complete remission: consolidation treatment by intensive radio-chemotherapy followed by transplantation of HLA-A, B and Dr compatible allogeneic bone marrow]M Gyger, C Perreault, Y Bonny, et al.
Bone Marrow Transplantation|September 14, 1999
Mycobacterium tuberculosis infection in allogeneic bone marrow transplantation patientsM Aljurf, M Gyger, A Alrajhi, et al.
Journal of Clinical Pathology|March 16, 2002
Extramedullary myeloid cell tumours localised to the mediastinum: a rare clinicopathological entity with unique karyotypic featuresR Nounou, H Al-Zahrani H, D S Ajarim, et al.
European Journal of Haematology|April 1, 1989
Chronic B-cell lymphocytosisC Perreault, J Boileau, M Gyger, et al.
British Journal of Haematology|December 1, 1993
Allogeneic bone marrow transplantation following busulfan-cyclophosphamide with or without etoposide conditioning regimen for patients with acute lymphoblastic leukaemiaA von Bueltzingsloewen, R Bélanger, C Perreault, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemiaG Pichert, D C Roy, R Gonin, et al.
British Journal of Haematology|April 12, 2000
The spectrum of Fusarium infection in immunocompromised patients with haematological malignancies and in non-immunocompromised patients: a single institution experience over 10 yearsM O Musa, A Al Eisa, M Halim, et al.
Leukemia & Lymphoma|August 3, 2002
Monitoring of donor/recipient T-cell engraftment kinetics in myeloablative allogeneic stem cell transplantation using short tandem repeat amplification from cell lysatesC E Boumah, B Meyer, M Aljurf, et al.
Experimental Hematology|May 20, 1998
Quantitative assessment of hematopoietic chimerism after allogeneic bone marrow transplantation has predictive value for the occurrence of irreversible graft failure and graft-vs.-host diseaseM Gyger, C Baron, L Forest, et al.
Cancer Chemotherapy and Pharmacology|May 13, 1999
Two different schedules for integrating filgrastim as adjuvant therapy in the treatment of patients with advanced stage Hodgkin's lymphoma receiving MOPP/ABV hybrid chemotherapyG Cantin, B L'Espérance, L Yelle, et al.
Pageof 9